Literature DB >> 16088272

Stopping bacterial adhesion: a novel approach to treating infections.

C Bavington1, C Page.   

Abstract

Adhesion and colonization are prerequisites for the establishment of bacterial pathogenesis. The prevention of adhesion is an attractive target for the development of new therapies in the prevention of infection. Bacteria have developed a multiplicity of adhesion mechanisms commonly targeting surface carbohydrate structures, but our ability to rationally design effective antiadhesives is critically affected by the limitations of our knowledge of the human 'glycome' and of the bacterial function in relation to it. The potential for the future development of carbohydrate-based antiadhesives has been demonstrated by a significant number of in vitro and in vivo studies. Such therapies will be particularly relevant for infections of mucosal surfaces where topical application or delivery is possible. (c) 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088272     DOI: 10.1159/000086243

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  16 in total

1.  Microelectrode array biosensor for studying carbohydrate-mediated interactions.

Authors:  Jeffrey W Chamberlain; Karl Maurer; John Cooper; Wanda J Lyon; David L Danley; Daniel M Ratner
Journal:  Biosens Bioelectron       Date:  2012-02-19       Impact factor: 10.618

2.  Anti-Porphyromonas gingivalis and anti-inflammatory activities of A-type cranberry proanthocyanidins.

Authors:  Vu Dang La; Amy B Howell; Daniel Grenier
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 3.  Receptor mimicry as novel therapeutic treatment for biothreat agents.

Authors:  Richard J Thomas
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

4.  Antimicrobial Activities of Salacia oblonga Wall Leaf and Root Extracts Against Different Bacterial Strains and Fungal Isolates.

Authors:  Challa Surekha; Racha Srikanth; Murali Krishna Thupurani; Nageswara Rao Reddy Neelapu; Vidyullatha Peddireddy
Journal:  Curr Microbiol       Date:  2022-05-25       Impact factor: 2.188

5.  Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation.

Authors:  Kamel Chaieb; Bochra Kouidhi; Hanene Jrah; Kacem Mahdouani; Amina Bakhrouf
Journal:  BMC Complement Altern Med       Date:  2011-04-13       Impact factor: 3.659

6.  Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.

Authors:  Tamir Dingjan; Anne Imberty; Serge Pérez; Elizabeth Yuriev; Paul A Ramsland
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

7.  Tannins possessing bacteriostatic effect impair Pseudomonas aeruginosa adhesion and biofilm formation.

Authors:  Danielle S Trentin; Denise B Silva; Matheus W Amaral; Karine R Zimmer; Márcia V Silva; Norberto P Lopes; Raquel B Giordani; Alexandre J Macedo
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Pre-treatment with EDTA-gallium prevents the formation of biofilms on surfaces.

Authors:  Yuanyuan Zhu; Feng Jin; Shuangwang Yang; Jingnong Li; Dan Hu; Lianming Liao
Journal:  Exp Ther Med       Date:  2013-02-05       Impact factor: 2.447

9.  Increased fucosyl glycoconjugate by Mycoplasma hyopneumoniae enhances adherences of Pasteurella multocida type A in the ciliated epithelial cells of the respiratory tract.

Authors:  Changhoon Park; Jiwoon Jeong; Ikjae Kang; Kyuhyung Choi; Su-Jin Park; Chanhee Chae
Journal:  BMC Vet Res       Date:  2016-02-03       Impact factor: 2.741

10.  Dietary yeast-derived mannan oligosaccharides have immune-modulatory properties but do not improve high fat diet-induced obesity and glucose intolerance.

Authors:  Lisa R Hoving; Hendrik J P van der Zande; Amanda Pronk; Bruno Guigas; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.